成本效益书架中的互斥干预措施。 - Suppr

Suppr

超能文献

Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf.

作者信息

Siverskog Jonathan, Henriksson Martin

机构信息

Centre for Medical Technology Assessment, Linköping University, Linköping, Sweden.

出版信息

Med Decis Making. 2020 Apr;40(3):399-403. doi: 10.1177/0272989X20912261. Epub 2020 Mar 14.

DOI:10.1177/0272989X20912261

PMID:32172657

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7241072/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f949/7241072/a7681ef5f2c8/10.1177_0272989X20912261-fig1.jpg

相似文献

Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf.

Med Decis Making. 2020 Apr;40(3):399-403. doi: 10.1177/0272989X20912261. Epub 2020 Mar 14.

Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.

Eur J Gastroenterol Hepatol. 2004 Jun;16(6):519-26. doi: 10.1097/00042737-200406000-00003.

Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.

Pharmacoeconomics. 2010;28(3):175-84. doi: 10.2165/11530650-000000000-00000.

[Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].

Psychiatr Prax. 2001 Jul;28 Suppl 1:S12-20. doi: 10.1055/s-2001-15382.

Determinants of Change in the Cost-effectiveness Threshold.

Med Decis Making. 2017 Feb;37(2):264-276. doi: 10.1177/0272989X16662242. Epub 2016 Sep 27.

Why not real economics?

Pharmacoeconomics. 2012 Feb 1;30(2):127-31. doi: 10.2165/11593350-000000000-00000.

Toward a broader view of values in cost-effectiveness analysis of health.

Hastings Cent Rep. 1999 May-Jun;29(3):7-15.

QALYs, standard gambles, and the expected budget constraint.

J Health Econ. 2002 Mar;21(2):181-95. doi: 10.1016/s0167-6296(01)00116-3.

Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment.

Value Health. 2019 Aug;22(8):898-905. doi: 10.1016/j.jval.2019.05.003. Epub 2019 Jul 30.

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.

Value Health. 2016 Dec;19(8):929-935. doi: 10.1016/j.jval.2016.02.017.

引用本文的文献

The ethics of aggregation in cost-effectiveness analysis or, "on books, bookshelves, and budget impact".

Front Health Serv. 2022 Oct 13;2:889423. doi: 10.3389/frhs.2022.889423. eCollection 2022.

本文引用的文献

Estimating the marginal cost of a life year in Sweden's public healthcare sector.

Eur J Health Econ. 2019 Jul;20(5):751-762. doi: 10.1007/s10198-019-01039-0. Epub 2019 Feb 22.

Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Pharmacoeconomics. 2018 May;36(5):509-522. doi: 10.1007/s40273-017-0606-1.

Estimating a cost-effectiveness threshold for the Spanish NHS.

Health Econ. 2018 Apr;27(4):746-761. doi: 10.1002/hec.3633. Epub 2017 Dec 28.

Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.

Pharmacoeconomics. 2018 Feb;36(2):239-252. doi: 10.1007/s40273-017-0585-2.

Determinants of Change in the Cost-effectiveness Threshold.

Med Decis Making. 2017 Feb;37(2):264-276. doi: 10.1177/0272989X16662242. Epub 2016 Sep 27.

Opportunity costs and local health service spending decisions: a qualitative study from Wales.

BMC Health Serv Res. 2016 Mar 25;16:103. doi: 10.1186/s12913-016-1354-1.

Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use.

Health Econ Policy Law. 2016 Oct;11(4):415-32. doi: 10.1017/S1744133116000049. Epub 2016 Feb 24.

Local health care expenditure plans and their opportunity costs.

Health Policy. 2015 Sep;119(9):1237-44. doi: 10.1016/j.healthpol.2015.07.007. Epub 2015 Jul 28.

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.

Searching for cost effectiveness thresholds in the NHS.

Health Policy. 2009 Aug;91(3):239-45. doi: 10.1016/j.healthpol.2008.12.010. Epub 2009 Jan 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf.

Med Decis Making. 2020 Apr;40(3):399-403. doi: 10.1177/0272989X20912261. Epub 2020 Mar 14.

Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.

Eur J Gastroenterol Hepatol. 2004 Jun;16(6):519-26. doi: 10.1097/00042737-200406000-00003.

Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.

Pharmacoeconomics. 2010;28(3):175-84. doi: 10.2165/11530650-000000000-00000.

[Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].

Psychiatr Prax. 2001 Jul;28 Suppl 1:S12-20. doi: 10.1055/s-2001-15382.

Determinants of Change in the Cost-effectiveness Threshold.

Med Decis Making. 2017 Feb;37(2):264-276. doi: 10.1177/0272989X16662242. Epub 2016 Sep 27.

Why not real economics?

Pharmacoeconomics. 2012 Feb 1;30(2):127-31. doi: 10.2165/11593350-000000000-00000.

Toward a broader view of values in cost-effectiveness analysis of health.

Hastings Cent Rep. 1999 May-Jun;29(3):7-15.

QALYs, standard gambles, and the expected budget constraint.

J Health Econ. 2002 Mar;21(2):181-95. doi: 10.1016/s0167-6296(01)00116-3.

Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment.

Value Health. 2019 Aug;22(8):898-905. doi: 10.1016/j.jval.2019.05.003. Epub 2019 Jul 30.

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.

Value Health. 2016 Dec;19(8):929-935. doi: 10.1016/j.jval.2016.02.017.

引用本文的文献

The ethics of aggregation in cost-effectiveness analysis or, "on books, bookshelves, and budget impact".

Front Health Serv. 2022 Oct 13;2:889423. doi: 10.3389/frhs.2022.889423. eCollection 2022.

本文引用的文献

Estimating the marginal cost of a life year in Sweden's public healthcare sector.

Eur J Health Econ. 2019 Jul;20(5):751-762. doi: 10.1007/s10198-019-01039-0. Epub 2019 Feb 22.

Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Pharmacoeconomics. 2018 May;36(5):509-522. doi: 10.1007/s40273-017-0606-1.

Estimating a cost-effectiveness threshold for the Spanish NHS.

Health Econ. 2018 Apr;27(4):746-761. doi: 10.1002/hec.3633. Epub 2017 Dec 28.

Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.

Pharmacoeconomics. 2018 Feb;36(2):239-252. doi: 10.1007/s40273-017-0585-2.

Determinants of Change in the Cost-effectiveness Threshold.

Med Decis Making. 2017 Feb;37(2):264-276. doi: 10.1177/0272989X16662242. Epub 2016 Sep 27.

Opportunity costs and local health service spending decisions: a qualitative study from Wales.

BMC Health Serv Res. 2016 Mar 25;16:103. doi: 10.1186/s12913-016-1354-1.

Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use.

Health Econ Policy Law. 2016 Oct;11(4):415-32. doi: 10.1017/S1744133116000049. Epub 2016 Feb 24.

Local health care expenditure plans and their opportunity costs.

Health Policy. 2015 Sep;119(9):1237-44. doi: 10.1016/j.healthpol.2015.07.007. Epub 2015 Jul 28.

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.

Searching for cost effectiveness thresholds in the NHS.

Health Policy. 2009 Aug;91(3):239-45. doi: 10.1016/j.healthpol.2008.12.010. Epub 2009 Jan 24.